Prelude Therapeutics Incorporated (PRLD)
NASDAQ: PRLD · Real-Time Price · USD
4.400
-0.220 (-4.76%)
Apr 22, 2026, 11:58 AM EDT - Market open
Prelude Therapeutics Market Cap
Prelude Therapeutics has a market cap or net worth of $442.43 million as of April 22, 2026. Its market cap has increased by 762.59% in one year.
Market Cap
442.43M
Enterprise Value
375.11M
1-Year Change
762.59%
Ranking
Category
Stock Price
$4.40
Market Cap Chart
Since the IPO on September 25, 2020, Prelude Therapeutics's market cap has decreased from $806.64M to $442.43M, a decrease of -45.15%. That is a compound annual growth rate of -10.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 21, 2026 | 381.31M | 59.58% |
| Dec 31, 2025 | 238.95M | 147.03% |
| Dec 31, 2024 | 96.73M | -70.04% |
| Dec 29, 2023 | 322.85M | 12.32% |
| Dec 30, 2022 | 287.43M | -50.22% |
| Dec 31, 2021 | 577.35M | -80.97% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 25, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nautilus Biotechnology | 383.49M |
| Cabaletta Bio | 382.95M |
| YD Bio | 382.54M |
| Puma Biotechnology | 380.05M |
| Monopar Therapeutics | 376.23M |
| Bicycle Therapeutics | 371.54M |
| DiaMedica Therapeutics | 369.10M |
| Surrozen | 362.52M |